Use of Convalescent Plasma to Treat COVID-19 Patients
Description
This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication.
Patients infected with SARS-CoV-2, the virus that causes COVID-19, develop antibodies against the virus that may help cure them of the infection. After the patient has recovered (convalesced) , they can donate their blood, which can be used to obtain antibody-rich plasma. The plasma is tested for strength and number of antibodies. If these levels are high enough, the plasma is given to a patient currently infected with COVID-19. If effective, the plasma will help cure infection in the new patient.
Acknowledgements
References
Bloch et. al.. (2020) Deployment of convalescent plasma for the prevention and treatment of COVID-19. JCI.
Casadevall et al. (2020) The convalescent sera option for containing COVID-19. JCI.
Get started with this template for freeDon’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures